This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lakhi, S.A. Articles by Beijnen, J.H. Search for Related Content PubMed Articles by Lakhi, S.A. Articles by Beijnen, J.H. Social Bookmarking                         What's this?

Hypersensitivity after ifosfamide administration

Department of Pharmacy, Netherlands Cancer Institute, Slotervaart Hospital, Amsterdam, the Netherlands

E.M. Bais

Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands

E.J.T. Rutgers

Department of Surgery, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands

J.H. Beijnen

Department of Pharmacy, Netherlands Cancer Institute, Slotervaart Hospital, Amsterdam, the Netherlands, Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands

The toxicity profile of the alkylating anti-cancer drug ifosfamide is quite well known. However, up to now only a few cases of hypersensitivity as an attributed adverse effect of ifosfamide have been described in literature.

This article describes the history of a woman suffering from a primary peripheral neuroectoder mal tumor (PNET) who was admitted to our hos pital for chemotherapy. Treatment was given ac cording to the EICESS-protocol (European Intergroup Cooperative Ewing's Sarcoma Study) with the following anti-cancer drugs: etoposide, doxorubicin, vincristine, and ifosfamide/mesna. Af ter ifosfamide administration an acute hypersensi tivity reaction was seen consisting of redness in the face and on the left arm, back and chest, and bronchoconstriction. Subsequent intravenous ad ministration of the anti-histaminic clemastine (2 mg) and dexamethasone (5 mg) before ifosfamide administration on a second occasion did not pre vent these reactions. After substituting cyclophos phamide for ifosfamide in consecutive courses no untoward reactions occurred.

Key Words: Ifosfamide • cyclophosphamide; hypersensitivity.

Journal of Oncology Pharmacy Practice, Vol. 2, No. 2, 113-116 (1996)
DOI: 10.1177/107815529600200204


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?